Neglected Tropical Diseases as a ‘litmus test’ for Universal Health Coverage? Understanding who is left behind and why in Mass Drug Administration: Lessons from four country contexts

Laura Dean; Kimberley Ozano; Oluwatosin Adekeye; Ruth Dixon; Ebua Gallus Fung; Margaret Gyapong; Sunday Isiyaku; Karsor Kollie; Vida Kukula; Luret Lar; Eleanor MacPherson; Christine Makia; Estelle Kouokam Magne; Dum Buo Nnamdi; Theobald Mue Nji; Uduak Ntuen; Akinola Oluwole; Helen Piotrowski; Marlene Siping; Marlene Ntsinda Tchoffo; Louis Albert Tchuem Tchuenté; Rachael Thomson; Irene Tsey; Samuel Wanji; James Yashiyi; Georgina Zawolo; Sally Theobald

doi:10.1371/journal.pntd.0007847

Neglected Tropical Diseases as a ‘litmus test’ for Universal Health Coverage? Understanding who is left behind and why in Mass Drug Administration: Lessons from four country contexts

Laura Dean
, Kimberley Ozano
, Oluwatosin Adekeye
, Ruth Dixon
, Ebua Gallus Fung
, Margaret Gyapong
, Sunday Isiyaku
, Karsor Kollie
, Vida Kukula
, Luret Lar
, Eleanor MacPherson
, Christine Makia
, Estelle Kouokam Magne
, Dum Buo Nnamdi
, Theobald Mue Nji
, Uduak Ntuen
, Akinola Oluwole
, Helen Piotrowski
, Marlene Siping
, Marlene Ntsinda Tchoffo

Louis Albert Tchuem Tchuenté, Rachael Thomson, Irene Tsey, Samuel Wanji, James Yashiyi, Georgina Zawolo, Sally Theobald

Research output: Contribution to journal › Article › peer-review

38 Citations (Scopus)

Abstract

Individuals and communities affected by NTDs are often the poorest and most marginalised; ensuring a gender and equity lens is centre stage will be critical for the NTD community to reach elimination goals and inform Universal Health Coverage (UHC). NTDs amenable to preventive chemotherapy have been described as a ‘litmus test’ for UHC due to the high mass drug administration (MDA) coverage rates needed to be effective and their model of community engagement. However, until now highly aggregated coverage data may have

masked inequities in availability, accessibility and acceptability of medicines, slowing down the equitable achievement of elimination goals.

Original language	English
Article number	e0007847
Pages (from-to)	e0007847
Journal	PLoS Neglected Tropical Diseases
Volume	13
Issue number	11
DOIs	https://doi.org/10.1371/journal.pntd.0007847
Publication status	Published - 21 Nov 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1371/journal.pntd.0007847Licence: CC BY

JournalFinal published version, 923 KBLicence: CC BY

Cite this

Dean, L., Ozano, K., Adekeye, O., Dixon, R., Fung, E. G., Gyapong, M., Isiyaku, S., Kollie, K., Kukula, V., Lar, L., MacPherson, E., Makia, C., Magne, E. K., Nnamdi, D. B., Nji, T. M., Ntuen, U., Oluwole, A., Piotrowski, H., Siping, M., ... Theobald, S. (2019). Neglected Tropical Diseases as a ‘litmus test’ for Universal Health Coverage? Understanding who is left behind and why in Mass Drug Administration: Lessons from four country contexts. PLoS Neglected Tropical Diseases, 13(11), e0007847. Article e0007847. https://doi.org/10.1371/journal.pntd.0007847

@article{093ba5b5aed14dcdb49076426227ed9f,

title = "Neglected Tropical Diseases as a {\textquoteleft}litmus test{\textquoteright} for Universal Health Coverage? Understanding who is left behind and why in Mass Drug Administration: Lessons from four country contexts",

abstract = "Individuals and communities affected by NTDs are often the poorest and most marginalised; ensuring a gender and equity lens is centre stage will be critical for the NTD community to reach elimination goals and inform Universal Health Coverage (UHC). NTDs amenable to preventive chemotherapy have been described as a {\textquoteleft}litmus test{\textquoteright} for UHC due to the high mass drug administration (MDA) coverage rates needed to be effective and their model of community engagement. However, until now highly aggregated coverage data may havemasked inequities in availability, accessibility and acceptability of medicines, slowing down the equitable achievement of elimination goals.",

author = "Laura Dean and Kimberley Ozano and Oluwatosin Adekeye and Ruth Dixon and Fung, \{Ebua Gallus\} and Margaret Gyapong and Sunday Isiyaku and Karsor Kollie and Vida Kukula and Luret Lar and Eleanor MacPherson and Christine Makia and Magne, \{Estelle Kouokam\} and Nnamdi, \{Dum Buo\} and Nji, \{Theobald Mue\} and Uduak Ntuen and Akinola Oluwole and Helen Piotrowski and Marlene Siping and Tchoffo, \{Marlene Ntsinda\} and Tchuent{\'e}, \{Louis Albert Tchuem\} and Rachael Thomson and Irene Tsey and Samuel Wanji and James Yashiyi and Georgina Zawolo and Sally Theobald",

year = "2019",

month = nov,

day = "21",

doi = "10.1371/journal.pntd.0007847",

language = "English",

volume = "13",

pages = "e0007847",

journal = "PLoS Neglected Tropical Diseases",

issn = "1935-2727",

publisher = "Public Library of Science",

number = "11",

}

Dean, L, Ozano, K, Adekeye, O, Dixon, R, Fung, EG, Gyapong, M, Isiyaku, S, Kollie, K, Kukula, V, Lar, L, MacPherson, E, Makia, C, Magne, EK, Nnamdi, DB, Nji, TM, Ntuen, U, Oluwole, A, Piotrowski, H, Siping, M, Tchoffo, MN, Tchuenté, LAT, Thomson, R, Tsey, I, Wanji, S, Yashiyi, J, Zawolo, G & Theobald, S 2019, 'Neglected Tropical Diseases as a ‘litmus test’ for Universal Health Coverage? Understanding who is left behind and why in Mass Drug Administration: Lessons from four country contexts', PLoS Neglected Tropical Diseases, vol. 13, no. 11, e0007847, pp. e0007847. https://doi.org/10.1371/journal.pntd.0007847

Neglected Tropical Diseases as a ‘litmus test’ for Universal Health Coverage? Understanding who is left behind and why in Mass Drug Administration: Lessons from four country contexts. / Dean, Laura; Ozano, Kimberley; Adekeye, Oluwatosin et al.
In: PLoS Neglected Tropical Diseases, Vol. 13, No. 11, e0007847, 21.11.2019, p. e0007847.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Neglected Tropical Diseases as a ‘litmus test’ for Universal Health Coverage? Understanding who is left behind and why in Mass Drug Administration: Lessons from four country contexts

AU - Dean, Laura

AU - Ozano, Kimberley

AU - Adekeye, Oluwatosin

AU - Dixon, Ruth

AU - Fung, Ebua Gallus

AU - Gyapong, Margaret

AU - Isiyaku, Sunday

AU - Kollie, Karsor

AU - Kukula, Vida

AU - Lar, Luret

AU - MacPherson, Eleanor

AU - Makia, Christine

AU - Magne, Estelle Kouokam

AU - Nnamdi, Dum Buo

AU - Nji, Theobald Mue

AU - Ntuen, Uduak

AU - Oluwole, Akinola

AU - Piotrowski, Helen

AU - Siping, Marlene

AU - Tchoffo, Marlene Ntsinda

AU - Tchuenté, Louis Albert Tchuem

AU - Thomson, Rachael

AU - Tsey, Irene

AU - Wanji, Samuel

AU - Yashiyi, James

AU - Zawolo, Georgina

AU - Theobald, Sally

PY - 2019/11/21

Y1 - 2019/11/21

N2 - Individuals and communities affected by NTDs are often the poorest and most marginalised; ensuring a gender and equity lens is centre stage will be critical for the NTD community to reach elimination goals and inform Universal Health Coverage (UHC). NTDs amenable to preventive chemotherapy have been described as a ‘litmus test’ for UHC due to the high mass drug administration (MDA) coverage rates needed to be effective and their model of community engagement. However, until now highly aggregated coverage data may havemasked inequities in availability, accessibility and acceptability of medicines, slowing down the equitable achievement of elimination goals.

AB - Individuals and communities affected by NTDs are often the poorest and most marginalised; ensuring a gender and equity lens is centre stage will be critical for the NTD community to reach elimination goals and inform Universal Health Coverage (UHC). NTDs amenable to preventive chemotherapy have been described as a ‘litmus test’ for UHC due to the high mass drug administration (MDA) coverage rates needed to be effective and their model of community engagement. However, until now highly aggregated coverage data may havemasked inequities in availability, accessibility and acceptability of medicines, slowing down the equitable achievement of elimination goals.

U2 - 10.1371/journal.pntd.0007847

DO - 10.1371/journal.pntd.0007847

M3 - Article

SN - 1935-2727

VL - 13

SP - e0007847

JO - PLoS Neglected Tropical Diseases

JF - PLoS Neglected Tropical Diseases

IS - 11

M1 - e0007847

ER -

Neglected Tropical Diseases as a ‘litmus test’ for Universal Health Coverage? Understanding who is left behind and why in Mass Drug Administration: Lessons from four country contexts

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this